Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

lamivudine triphosphate

Known as: 3TC-TP 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
Our previous negative ESI-LC-MS/MS method developed for nucleoside reverse transcriptase inhibitor (NRTI) triphosphate (-TP… Expand
Highly Cited
2006
Highly Cited
2006
BACKGROUND Emodin (1, 3, 8-trihvdroxy-6-methylanthraquinone) is derived from herbal medicines and proved to have a strong… Expand
Highly Cited
2003
Highly Cited
2003
Objectives: Nucleoside analog reverse transcriptase inhibitors (NRTI) are used in virtually all anti-HIV regimens. Clinical… Expand
2002
2002
ABSTRACT Mutations in the YMDD motif of the hepatitis B virus (HBV) DNA polymerase result in reduced susceptibility of HBV to… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2002
Review
2002
  • F. Zoulim
  • Seminars in liver disease
  • 2002
  • Corpus ID: 42381330
The development of viral resistance to drugs can significantly reduce the efficacy of therapy for chronic hepatitis B virus (HBV… Expand
2002
2002
Background: Nucleoside analogues are activated to their triphosphates, which compete with endogenous deoxynucleoside triphosphate… Expand
2001
2001
Cross-resistance between zidovudine, stavudine, and lamivudine was studied, using purified recombinant reverse transcriptase from… Expand
  • figure 1
  • table 1
Highly Cited
2000
Highly Cited
2000
ObjectiveTo quantitate intracellular concentrations of zidovudine and lamivudine triphosphate and explore relationships with… Expand
Highly Cited
2000
Highly Cited
2000
Several mutations (V521L, P525L, L528M, T532S, and V555I) in the gene for hepatitis B virus (HBV) polymerase have been identified… Expand
1999
1999
ABSTRACT Nucleoside reverse transcriptase inhibitors (NRTIs) used against the human immunodeficiency virus (HIV) need to be… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3